Daniel Griffith Anderson - Jun 2, 2021 Form 4 Insider Report for Sigilon Therapeutics, Inc. (SGTX)

Role
Director
Signature
/s/ Matthew Kowalsky, Attorney-in-Fact
Stock symbol
SGTX
Transactions as of
Jun 2, 2021
Transactions value $
-$2,000,000
Form type
4
Date filed
6/4/2021, 04:15 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGTX Common Stock Sale -$2M -200K -9% $10.00 2.02M Jun 2, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.